BLTE · Belite Bio, Inc
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-18 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. |
American depositary share
(I)
|
96 |
| 2026-06-18 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. |
American depositary share
(I)
|
96 |
| 2026-06-18 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $145 to $145.94. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
4,861 |
| 2026-06-18 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $146.005 to $146.755. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
1,199 |
| 2026-06-18 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $144.07 to $144.995. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
3,748 |
| 2026-06-16 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $140.325 to $140.825. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
540 |
| 2026-06-16 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $145.02 to $145.6. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
1,035 |
| 2026-06-16 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. |
American depositary share
(I)
|
100 |
| 2026-06-16 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $143.035 to $143.915. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
1,897 |
| 2026-06-16 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $139.01 to $139.9575. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
3,140 |
| 2026-06-16 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $142.14 to $142.24. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
450 |
| 2026-06-16 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $137.19 to $137.9. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
2,054 |
| 2026-06-16 | Scholl Hendrik Peter |
Chief Medical Officer |
Sell↓
Filing footnotes — American depositary share (Indirect)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. Represents the weighted average price of shares sold at prices that ranged from $138 to $138.74. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
(I)
|
784 |
| 2026-05-07 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. |
American depositary share
|
3 |
| 2026-05-07 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $155.18 to $155.29. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
9 |
| 2026-05-07 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $153.1 to $153.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
428 |
| 2026-05-07 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $152.35 to $152.68. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
226 |
| 2026-05-06 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $153 to $153.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
128 |
| 2026-05-06 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. |
American depositary share
|
100 |
| 2026-05-06 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $151.17 to $151.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
8 |
| 2026-05-06 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. |
American depositary share
|
100 |
| 2026-05-06 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $154.02 to $154.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
240 |
| 2026-05-06 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $152.25 to $152.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
424 |
| 2026-05-05 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $157.035 to $157.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
155 |
| 2026-05-05 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $155.04 to $155.91. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
173 |
| 2026-05-05 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $156.005 to $156.94. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
121 |
| 2026-05-05 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $154.01 to $154.955. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
363 |
| 2026-05-05 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. |
American depositary share
|
68 |
| 2026-05-05 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $153.92 to $153.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
120 |
| 2026-05-04 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $157.05 to $157.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
172 |
| 2026-05-04 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $153.05 to $153.855. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
32 |
| 2026-05-04 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $155.02 to $155.96. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
325 |
| 2026-05-04 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $156 to $156.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
235 |
| 2026-05-04 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $154.06 to $154.925. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
236 |
| 2026-05-01 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $153.8 to $153.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
52 |
| 2026-05-01 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. |
American depositary share
|
23 |
| 2026-05-01 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $156 to $156.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
82 |
| 2026-05-01 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $159 to $159.47. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
38 |
| 2026-05-01 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $154 to $154.86. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
288 |
| 2026-05-01 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $155 to $155.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
346 |
| 2026-05-01 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $158 to $158.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
65 |
| 2026-05-01 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $157.15 to $157.9. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
106 |
| 2026-04-30 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $155.62 to $155.87. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
42 |
| 2026-04-30 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $158.01 to $158.42. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
101 |
| 2026-04-30 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $156.095 to $156.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
517 |
| 2026-04-30 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $157 to $157.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
340 |
| 2026-04-29 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $155.02 to $155.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
259 |
| 2026-04-29 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $157 to $157.9. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
102 |
| 2026-04-29 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $154.22 to $154.96. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
278 |
| 2026-04-29 | MATA NATHAN L. |
Chief Scientific Officer |
Sell↓
Filing footnotes — American depositary share (Direct)
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. Represents the weighted average price of shares sold at prices that ranged from $156 to $156.96. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
American depositary share
|
339 |